Institutional Development Plan (2024-2029)
Manav Institute of Pharmacy is committed to quality-driven education, research advancement, and community engagement in line with NAAC benchmarks. This Institutional Development Plan (2024–2029) focuses on achieving academic excellence, accreditation, and autonomy while strengthening research output and introducing postgraduate program. Emphasis is placed on faculty and student development, curriculum enhancement, industry linkages, and sustainable infrastructure.
Committee Composition
| Feature | Name | Designation | Area of Expertise |
|---|---|---|---|
| 1 | Dr. C. P. Gupta | Chief Academic Advisor | Academic Planning, OBE, Curriculum Reform |
| 2 | Dr. Seema Gupta | Research & Quality Consultant | NAAC Documentation, Research, SSR/AQAR |
| 3 | Dr. Kiran Bagri | Institutional Development Coordinator | Pharmacy Education, Faculty Development, Policy Implementation |
| 4 | Mr. Sudhir Nain | Governance & Policy Advisor | Institutional Governance, Strategic Planning, Ethics |
| 5 | Mr. Rammehar | Innovation & Industry Linkage Advisor | Research Innovation, Pharma Industry Collaboration, IPR |
Advisors and Consultants Roles and Responsibilities:
Dr. C. P. Gupta:
Lead academic audits, curriculum benchmarking, and mentoring for outcome-based learning systems.
Dr. Seema Gupta:
Dr. Kiran Bagri
Mr. Sudhir Nain
Mr. Rammehar
Functions of the Committee:
Prepare and review the Institutional Development Plan (IDP)
Align institutional goals with NAAC’s 7 Criteria and NEP 2020
Conduct internal quality audits and mock NAAC assessments
Facilitate faculty training, seminars, and best practice workshops
Outside Promoters
| Feature | Name | Designation | Area of Expertise |
|---|---|---|---|
| 1 | Dr. V.K. Gupta | Senior Academic Consultant | Higher education policy, curriculum development, quality assurance |
| 2 | Dr. B.D. Chaudary | NAAC Accreditation Expert | Institutional assessment, SSR preparation, governance frameworks |
| 3 | Mrs. Vidya Gupta | Educational Advisor | Teaching-learning process, academic planning, student engagement |
Vision
To become a leading institution in pharmacy education and research, fostering innovation, leadership, and quality healthcare solutions. Vision Statement Explanation “To establish Manav Institute of Pharmacy as a nationally recognized center of excellence in pharmaceutical education, research, and innovation, committed to nurturing competent, ethical, and socially responsible pharmacy professionals.”
Vision and Mission Objectives of the Institute
| Feature | Component | Explanation |
|---|---|---|
| 1 | National Recognition | To achieve national recognition through |
Purpose of This Vision
This vision guides long-term institutional planning, resource allocation, and academic strategies. It ensures that every action taken over 2024–2029 aligns with the aspiration to become a leader in pharmacy education and a contributor to national healthcare development.
Mission
To deliver world-class pharmaceutical education, advance research and innovation, and produce socially responsible pharmacists equipped to tackle global healthcare challenges.
Mission Statement (2024–2029)
Academic Excellence: To deliver outcome-based education through a student-centric, industry-integrated curriculum that fosters innovation and critical thinking.
Research & Innovation: To strengthen research capabilities by encouraging interdisciplinary projects, collaborations, and translational research.
Industry & Community Engagement: To build sustainable partnerships with pharmaceutical industries, healthcare institutions, and community organizations for mutual growth.
Holistic Development: To cultivate leadership, ethics, and soft skills in students, preparing them for global professional challenges.
Quality Assurance: To promote a culture of continuous improvement through effective implementation of quality benchmarks and best practices.
Achieving Accreditation and Advancing Autonomy (2024–2029)
To achieve NAAC accreditation and subsequently apply for institutional autonomy to enhance academic and operational flexibility
Goal 1
Initiate the NAAC accreditation process through self-assessment and compliance with quality benchmarks
Goal 2
Strengthen academic, administrative, and infrastructural systems to meet NAAC criteria.
Goal 2
Engage expert advisors to guide the accreditation journey and ensure quality enhancement.
Goal 2
Post-accreditation, apply for UGC-recognized autonomy to promote curriculum innovation, faculty empowerment, and improved institutional governance.
Advancing Academic Programs (2024-2029)
To strengthen academic quality and expand academic offerings through the introduction of advanced programs like M.Pharm, while continuously updating curricula to reflect evolving healthcare and pharmaceutical trends.
Launch of Post- Graduate Programs ( M.Pharm):
Develop postgraduate programs in pharmaceutical sciences, pharmacology, pharmaceutical chemistry and drug development with both research- and coursework-based options. Collaborate with healthcare and industry experts to design relevant, skill-driven curricula.
Modernize Content
Integrate emerging domains like digital health, pharmacogenomics, AI in pharmacy, and biotechnology.
Flexible Learning
Provide online modules, workshops, and webinars alongside hands-on learning through internships and clinical rotations.
Promote Research Culture
Encourage research-based learning and industry collaboration to solve real-world pharmaceutical challenges.
Research Advancement and Innovation Ecosystem
To build a dynamic research ecosystem and innovation culture in pharmaceutical sciences through specialized centers, high-quality output, and industry-academia collaboration.
Research Infrastructure:
Set up specialized research centers (e.g., drug discovery, pharmacogenomics). Develop advanced labs for UG and PG research. Attract funding through industry and government collaborations.
Faculty and Student Research Promotion
Provide grants and seed funding for research projects. Encourage publications in UGC listed and indexed journals. Support participation in national/international conferences.
Innovation, Patents & Commercialization
Conduct workshops on IPR and patent filing. Offer incentives for research papers and patentable innovations.
Institutional Infrastructure Enhancement (2024–2029)
To enhance academic, research, and student-centered infrastructure to support high-quality education and innovation.
Development of Research Ecosystem:
Upgrade laboratories with modern equipment for drug formulation, bioanalysis, and clinical research. Establish simulation labs for M.Pharm training aligned with global clinical standards.
Academic & Student Spaces:
Expand interactive classrooms with smart teaching tools. Develop student-centric areas such as study lounges, research corners, and collaborative workspaces.
Digital Learning Resources:
Strengthen access to global journals, e-books, and databases. Launch a dedicated e-learning platform for online courses, webinars, and digital learning modules.
Faculty Development and Retention (2024–2029)
To build and retain a highly qualified faculty capable of delivering excellence in teaching, research, and community engagement
Faculty Recruitment and Training:
Attract experts in pharmacy, drug development, and pharmaceutical policy through competitive hiring strategies. Conduct regular faculty development programs, research seminars, and provide access to online learning platforms.
Incentivizing Excellence:
Introduce awards for outstanding performance in teaching, research, and service. Support faculty through sabbaticals, research leave, and international collaboration opportunities.
Mission Brief
Curriculum Excellence
Implementation of outcome-based education, ICT tools, and value-added courses.
Faculty Development
Student Empowerment
Research & Innovation
Infrastructure Upgradation
Quality Assurance
Community Outreach
Strategies for Financial Mobilization (2024–2029)
Availing government grants from UGC AICTE DBT DST PCI and RUSA
Generating revenue through industry-sponsored research and testing services
Establishing alumni association for donations scholarships and infrastructure support
Signing MoUs with pharmaceutical industries for sponsored labs and training programs
Introducing self-financed certificate and diploma programs in emerging pharmacy fields
Partnering with companies under CSR for community outreach and innovation projects
Seeking funding from NGOs trusts and philanthropic foundations for institutional development
--
--
--
---